MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
Rigel Pharmaceuticals Total Inventories 2011-2026 | RIGL
Annual Total Inventories Rigel Pharmaceuticals
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6 M | 5.52 M | 9.12 M | 6.62 M | 1.64 M | 1.35 M | 894 K | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 9.12 M | 894 K | 4.45 M |
Quarterly Total Inventories Rigel Pharmaceuticals
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13.3 M | 10.4 M | 4.66 M | 4.78 M | 8.06 M | 6.58 M | 6.11 M | 10.8 M | 11.1 M | 9.12 M | 7.12 M | - | 6.76 M | 6.62 M | 7.04 M | 6.83 M | 6.95 M | 1.64 M | 1.64 M | 1.64 M | 1.64 M | 1.35 M | 1.35 M | 1.35 M | 1.35 M | 894 K | 894 K | 894 K | 894 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 13.3 M | 894 K | 5.06 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Apellis Pharmaceuticals
APLS
|
143 M | $ 20.29 | -1.98 % | $ 2.56 B |  USA |
 |
Aptorum Group Limited
APM
|
39.1 K | $ 0.8 | -5.3 % | $ 4.36 M |  China |
 |
Axsome Therapeutics
AXSM
|
27.9 M | $ 166.0 | -0.23 % | $ 8.26 B | USA |
 |
AbCellera Biologics
ABCL
|
6.34 M | $ 3.74 | -2.23 % | $ 1.12 B |  Canada |
 |
Catalyst Pharmaceuticals
CPRX
|
37.2 M | $ 23.78 | -0.42 % | $ 2.91 B | USA |
 |
Eton Pharmaceuticals
ETON
|
911 K | $ 17.9 | -1.38 % | $ 459 M | USA |
 |
Exelixis
EXEL
|
21.7 M | $ 40.5 | -1.29 % | $ 11 B | USA |
 |
Acorda Therapeutics
ACOR
|
16.2 M | - | -24.86 % | $ 820 K | USA |
 |
Codexis
CDXS
|
1.8 M | $ 1.02 | -0.33 % | $ 74.9 M | USA |
 |
Halozyme Therapeutics
HALO
|
176 M | $ 68.58 | -1.82 % | $ 8.22 B | USA |
 |
Harmony Biosciences Holdings
HRMY
|
5.36 M | $ 28.32 | -2.01 % | $ 1.63 B | USA |
 |
ImmuCell Corporation
ICCC
|
7.11 M | $ 6.3 | -3.67 % | $ 51.5 M | USA |
 |
Agenus
AGEN
|
55.5 K | $ 3.27 | -2.1 % | $ 1.17 M | USA |
 |
Agios Pharmaceuticals
AGIO
|
32.9 M | $ 28.57 | -2.16 % | $ 1.66 B | USA |
 |
InMed Pharmaceuticals
INM
|
1.62 M | $ 0.8 | -2.44 % | $ 1.96 M | Canada |